MX368306B - Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos. - Google Patents

Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos.

Info

Publication number
MX368306B
MX368306B MX2015007947A MX2015007947A MX368306B MX 368306 B MX368306 B MX 368306B MX 2015007947 A MX2015007947 A MX 2015007947A MX 2015007947 A MX2015007947 A MX 2015007947A MX 368306 B MX368306 B MX 368306B
Authority
MX
Mexico
Prior art keywords
horses
treatment
ciclesonide
airway disease
disease
Prior art date
Application number
MX2015007947A
Other languages
English (en)
Other versions
MX2015007947A (es
Inventor
Lang Ingo
Aven Michael
Albrecht Balazs
Lamar Janine
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX368306(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2015007947A publication Critical patent/MX2015007947A/es
Publication of MX368306B publication Critical patent/MX368306B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere al campo de la medicina, en particular al campo de medicina veterinaria. La invención se refiere a glucocorticoides, en especial ciclesonida o un derivado farmacéuticamente aceptable de este, para el tratamiento de la enfermedad de las vías respiratorias en caballos, tal como enfermedad pulmonar, con preferencia obstrucción de vías respiratorias recurrente (RAO), Enfermedad pulmonar obstructiva asociada con las pasturas de verano (SPAOPD), y enfermedad inflamatoria de las vías respiratorias (IAD).
MX2015007947A 2012-12-21 2013-12-18 Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos. MX368306B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (2)

Publication Number Publication Date
MX2015007947A MX2015007947A (es) 2015-10-08
MX368306B true MX368306B (es) 2019-09-27

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007947A MX368306B (es) 2012-12-21 2013-12-18 Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos.

Country Status (24)

Country Link
US (4) US9918995B2 (es)
EP (1) EP2934479B1 (es)
AR (1) AR094241A1 (es)
AU (2) AU2013360691B2 (es)
BR (2) BR122016029247A2 (es)
CA (1) CA2888428C (es)
CY (2) CY1121115T1 (es)
DK (1) DK2934479T3 (es)
ES (1) ES2693779T3 (es)
FR (1) FR20C1026I1 (es)
HR (1) HRP20181980T1 (es)
HU (1) HUS2000020I1 (es)
IN (1) IN2015DN02894A (es)
LT (2) LT2934479T (es)
MA (1) MA38169B2 (es)
MX (1) MX368306B (es)
NO (1) NO2020014I1 (es)
NZ (1) NZ706573A (es)
PL (1) PL2934479T3 (es)
PT (1) PT2934479T (es)
RS (1) RS57740B1 (es)
SI (1) SI2934479T1 (es)
WO (1) WO2014096115A1 (es)
ZA (1) ZA201502288B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014001556A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Composicion farmaceutica de sabor enmascarado.
SI2934479T1 (sl) 2012-12-21 2019-01-31 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih
EP2934544B1 (en) 2012-12-21 2018-11-07 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical formulation comprising ciclesonide
MX370430B (es) 2014-06-18 2019-12-13 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos.
WO2018070819A1 (ko) * 2016-10-14 2018-04-19 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
EP4087581A1 (en) * 2020-01-10 2022-11-16 Boehringer Ingelheim Vetmedica GmbH Ciclesonide for ameliorating quality of life (qol) in equines
US20230270754A1 (en) 2020-07-31 2023-08-31 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US20040053902A1 (en) 2002-09-13 2004-03-18 Smith C. Steven Novel composition and method for treatment of upper respiratory conditions
EP1635844A1 (en) 2003-05-22 2006-03-22 ALTANA Pharma AG Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1740188A1 (en) 2004-04-20 2007-01-10 Altana Pharma AG Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1763344A1 (en) 2004-06-29 2007-03-21 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
JP2012530567A (ja) 2009-06-25 2012-12-06 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入器
US7829748B1 (en) * 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
EA201590030A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
EP2934544B1 (en) 2012-12-21 2018-11-07 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical formulation comprising ciclesonide
SI2934479T1 (sl) 2012-12-21 2019-01-31 Boehringer Ingelheim Vetmedica Gmbh Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih
ES2837948T3 (es) 2013-08-20 2021-07-01 Boehringer Ingelheim Vetmedica Gmbh Inhalador
SI3035885T1 (sl) 2013-08-20 2020-04-30 Boehringer Ingelheim Vetmedica Gmbh Inhalator
MX370430B (es) 2014-06-18 2019-12-13 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos.

Also Published As

Publication number Publication date
CY2020015I1 (el) 2020-11-25
HRP20181980T1 (hr) 2019-01-25
BR112015010842B1 (pt) 2021-03-30
NZ706573A (en) 2019-11-29
EP2934479B1 (en) 2018-09-19
US20170079988A1 (en) 2017-03-23
AU2013360691A1 (en) 2015-04-16
MX2015007947A (es) 2015-10-08
MA38169A1 (fr) 2017-01-31
AU2018201642A1 (en) 2018-03-29
US20140179651A1 (en) 2014-06-26
LT2934479T (lt) 2018-12-27
HUS2000020I1 (hu) 2020-07-28
BR122016029247A2 (pt) 2019-08-20
AU2018201642B2 (en) 2019-01-31
SI2934479T1 (sl) 2019-01-31
ZA201502288B (en) 2019-09-25
US9918995B2 (en) 2018-03-20
RS57740B1 (sr) 2018-12-31
CY1121115T1 (el) 2019-12-11
US20180153907A1 (en) 2018-06-07
EP2934479A1 (en) 2015-10-28
CA2888428A1 (en) 2014-06-26
LTPA2020511I1 (lt) 2020-07-27
BR112015010842A2 (pt) 2017-07-11
PL2934479T3 (pl) 2019-02-28
CY2020015I2 (el) 2021-03-12
AU2013360691B2 (en) 2018-03-08
IN2015DN02894A (es) 2015-09-11
FR20C1026I1 (fr) 2020-10-02
US10441597B2 (en) 2019-10-15
BR112015010842A8 (pt) 2019-10-01
CA2888428C (en) 2021-07-13
US20150313918A1 (en) 2015-11-05
NO2020014I1 (no) 2020-06-12
ES2693779T3 (es) 2018-12-13
DK2934479T3 (en) 2018-11-05
AR094241A1 (es) 2015-07-22
PT2934479T (pt) 2018-12-20
US10258634B2 (en) 2019-04-16
WO2014096115A1 (en) 2014-06-26
MA38169B2 (fr) 2021-08-31

Similar Documents

Publication Publication Date Title
ZA202004764B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HUE053113T2 (hu) Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
IN2015DN02894A (es)
MX2014000341A (es) Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.
WO2014179564A8 (en) Thiazolopyrrolidine inhibitors of ror-gamma
IN2014DN09352A (es)
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
MX2015017964A (es) Inhibidores de bromodominio.
MX2019014935A (es) Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.
LT2726511T (lt) Kompozicijos, panaudojimai ir būdai, skirti metabolinių sutrikimų ir ligų gydymui
WO2014151456A3 (en) Treatment of inflammatory diseases
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA032951B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
IN2014DN09347A (es)
HK1217092A1 (zh) 治疗性化合物及其用途
PH12012501389A1 (en) Hedgehog inhibitors
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
MX2015001657A (es) Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar).
WO2014138616A3 (en) Pyrazole compounds and methods of use thereof
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
IN2013MU03429A (es)

Legal Events

Date Code Title Description
FG Grant or registration